Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand ; volume:50 ; number:9 ; day:15 ; month:4 ; year:2023 ; pages:2872-2884 ; date:7.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 9 (15.4.2023), 2872-2884, 7.2023
- Urheber
-
Derks, Yvonne H. W.
Schilham, Melline G. M.
Rijpkema, Mark
Smeets, Esther M. M.
Amatdjais-Groenen, Helene I. V.
Kip, Annemarie
Lith, Sanne A. M. van
Kamp, Jill van de
Sedelaar, J. P. Michiel
Somford, Diederik M.
Simons, Michiel
Laverman, Peter
Gotthardt, Martin
Löwik, Dennis W. P. M.
Heskamp, Sandra
Lütje, Susanne
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06224-1
- URN
-
urn:nbn:de:101:1-2023093011110406869602
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Derks, Yvonne H. W.
- Schilham, Melline G. M.
- Rijpkema, Mark
- Smeets, Esther M. M.
- Amatdjais-Groenen, Helene I. V.
- Kip, Annemarie
- Lith, Sanne A. M. van
- Kamp, Jill van de
- Sedelaar, J. P. Michiel
- Somford, Diederik M.
- Simons, Michiel
- Laverman, Peter
- Gotthardt, Martin
- Löwik, Dennis W. P. M.
- Heskamp, Sandra
- Lütje, Susanne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer
Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer
Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer
Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway